Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Galena Bio's NeuVax improves disease-free survival at 60-month median follow-up
Galena Bio's NeuVax improves disease-free survival at 60-month median follow-up
Galena Bio's NeuVax improves disease-free survival at 60-month median follow-up
Submitted by
admin
on June 5, 2012 - 12:23pm
Source:
Yahoo/Fly on the Wall
News Tags:
Galena Biopharma
NeuVax
Headline:
Galena Bio's NeuVax improves disease-free survival at 60-month median follow-up
Do Not Allow Advertisers to Use My Personal information
